Rapid detection of Chlamydia & Gonorrhea

The first CLIA-Waived PCR point-of-care solution for the rapid detection of chlamydia & gonorrhea

Members have exclusive contract pricing through Medline

Create an account to learn more about membership benefits and pricing.
Sign Up
  • Clipboard-check icon

    Fastest molecular CT/NG test for males and females - allows true test and treat

  • Clipboard-check icon

    Laboratory performance in 30 minutes


  • Clipboard-check icon

    Fully automated, very easy to use by non-lab-trained personnel

  • Clipboard-check icon

    Approximately 1-minute hands-on time per patient sample

  • Clipboard-check icon

    No interpretation of results required

  • Clipboard-check icon

    Reimbursement codes established

  • Clipboard-check icon

    Established CPT codes with reimbursement already in place

    Billable with established CPT codes Chlamydia Test 87491 Gonorrhea Test 87591 Infectious Agent, Multiple Organisms & 87801

Doctor prepares syringe

The current testing model for CT/NG is very inefficient. The time between sample collection and treatment can take between 1- 10 days. 1

  • Patients must be called with their results and then return for treatment.
  • With empiric treatment, antibiotics are often given when they are not needed (poor antibiotic stewardship).2

The binx io enables a test & treat model that may help the patient, provider and community improve access to CT/NG diagnostic testing and care.
‍

What's in it for me?
‍‍

Why the binx io is important for me. The binx io CT/NG Assay System:

  • Is first of its kind
  • Creates a stream of consistent revenue
  • Is not a seasonal respiratory test that comes and goes, but rather a steady state of testing
  • Is CLIA-waived and fits into many places within a health system
  • Test and Treat in single visit. No call-backs!
  • Grow your patient base

The binxs io brings central lab accuracy to the POC

  • Nine sites across US participated in the clinical study, comprising of STI, OBGYN, HIV and family planning clinics
  • A total of 2,455 asymptomatic and symptomatic subjects were recruited
  • 50% of female samples were self collected, 50% clinician-collected according to a pre-determined randomization schedule

Prospective Clinical study: performance measured against three establish Laboratory platforms

Roche logoHologic logoBD logo
STI: Sexually Transmitted Infection
FDA 510(k) Clinical Study

Processing Patient Samples is as easy as 1,2, 3

Cleared for asymptamatic and symptomatic specimen collection. Fits easily into laboratyory space or clinic
Collect
Processing Samples step1
Vaginal swab/male urine sample collected and transferred to a specimen collection tube
Prepare
Processing Samples step2
Use the sample transfer pipet included in the cartridge pouch to transfer specimen from tube to cartridge
Test
Processing Samples step3
Insert cartridge into io instrument and follow the on-screen prompts to get results in about 30 minutes
Publications:
Assessing the clinical impact and resource use of a 30-minute chlamydia and gonorrhoea point-of-care test at three sexual health services binx health Time Motion Study Poster in collaboration with Cinncinati Children's presented at the 2023 STI HIV World Congress Van Der Pol et al. published in JAMA in 2020- Evaluation of the Performance of a Point- of-Care Test for Chlamydia and Gonorrhea Gettinger, J.et al. (2020). Patients are willing to wait for rapid sexually transmitted infection results in a university student health clinic. Sexually Transmitted Diseases, 47(1), 67–69.
‍
Collateral:
The first CLIA-Waived PCR point-of-care solution for the rapid detection of chlamydia & gonorrhea Clinical Workflow Postcard

Join PBG Today

Get access to these benefits by joining PBG

Start Now

We make it easy to do more for your patients and practice.

Create an account to learn more about membership benefits and pricing.
Sign Up
Physicians’ Buying Group © 2024